← Back to Search
The Common Mechanisms Of Sarcopenia And NAFLD
Yu Zhai, Qian Xiao
Published 2017 · Medicine
Download PDFAnalyze on Scholarcy
Current studies have shown that sarcopenia and nonalcoholic fatty liver disease (NAFLD) have similar pathophysiological profiles. The cooccurrence of sarcopenia and NAFLD has been observed in elderly patients. The actions of these conditions are linked, and their treatments are similar. Therefore, studies should be conducted on NAFLD-sarcopenia rather than on NAFLD or sarcopenia.
This paper references
Discovering pathways of sarcopenia in older adults: A role for insulin resistance on mitochondria dysfunction
A. Abbatecola (2011)
Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway
C. Zhang (2011)
Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
C. V. Tovo (2017)
Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.
T. Takamura (2012)
Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective
M. Conte (2016)
No Significant Association Between Vitamin D and Nonalcoholic Fatty Liver Disease in a Chinese Population
L. Li (2013)
Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia.
E. Wilkes (2009)
Is the adiponectin‐AMPK‐mitochondrial axis involved in progression of nonalcoholic fatty liver disease?
S. Dasarathy (2014)
Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll‐like receptor activation
C. Roth (2012)
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
R. A. Bhanji (2017)
Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study
H. Hong (2014)
The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
Y. Hashimoto (2016)
Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle
L. Ceglia (2010)
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
H. Y. Kim (2016)
Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans
C. Guillet (2004)
Causes and metabolic consequences of Fatty liver.
N. Stefan (2008)
BioMed Research International examination survey III
Sarcopenia: European consensus on definition and diagnosis
A. Cruz-Jentoft (2010)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
C. Postic (2008)
Insulin resistance of muscle protein metabolism in aging
B. Rasmussen (2006)
Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study.
M. Cesari (2005)
Aerobic Exercise Overcomes the Age-Related Insulin Resistance of Muscle Protein Metabolism by Improving Endothelial Function and Akt/Mammalian Target of Rapamycin Signaling
S. Fujita (2007)
Vitamin D attenuates high fat diet–induced hepatic steatosis in rats by modulating lipid metabolism
Y. Yin (2012)
Vitamin D and Health: Perspectives From Mice and Man
R. Bouillon (2008)
Prevention of NSAID-Enteropathy: A Soluble Problem?
J. Wallace (2015)
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
H. Tilg (2008)
Sarcopenia: origins and clinical relevance.
I. Rosenberg (1997)
Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.
M. Hamaguchi (2012)
Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1
D. Cabrera (2016)
Insulin resistance: a contributing factor to age-related muscle mass loss?
C. Guillet (2005)
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
M. Cesari (2010)
Chronic low-grade inflammation and age-related sarcopenia
I. Beyer (2012)
Meta‐analysis: vitamin D and non‐alcoholic fatty liver disease
M. Eliades (2013)
Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.
M. Visser (2003)
Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
E. Poggiogalle (2016)
Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
I. Barchetta (2011)
Vitamin D and skeletal muscle tissue and function.
L. Ceglia (2008)
Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III
P. Srikanthan (2010)
Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Y. Lee (2015)
Insulin resistance: A contributing factor to age-relatedmuscle mass loss?”Diabetes &Metabolism
C. Guillet (2005)
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
K. Utzschneider (2006)
A prospective study of the associations between 25‐hydroxy‐vitamin D, sarcopenia progression and physical activity in older adults
D. Scott (2010)
Shedding new light on vitamin D and fatty liver disease.
A. Geier (2011)
Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
A. Wree (2010)
Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis
Haitham A. Abdulla (2015)
Adiponectin and its receptors in non-alcoholic steatohepatitis
S. Kaser (2005)
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.
M. Lazo (2013)
Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism
S. Fujita (2009)
1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells.
L. García (2011)
Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the national health and nutrition 4 BioMed Research International examination survey III
P. Srikanthan (2010)
Active vitamin D possesses beneficial effects on the interaction between muscle and bone.
K. Tanaka (2014)
Association Between Visceral Obesity and Sarcopenia and Vitamin D Deficiency in Older Koreans: The Ansan Geriatric Study
J. A. Seo (2012)
Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity.
S. Bonala (2013)
This paper is referenced by
Relative skeletal muscle mass and non-alcoholic fatty liver disease: from association to causation.
H. Kim (2019)
Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.
Toshifumi Yodoshi (2020)
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
P. Golabi (2020)
SARCOPENIA AND SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE.
Josilda Ferreira Cruz (2019)
Building mass to prevent non-alcoholic fatty liver disease?
S. Pelusi (2019)
Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
I. Mikolasevic (2020)
Sarcopenia and nonalcoholic fatty liver
The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass
E. Choe (2018)
Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)
K. S. Hong (2020)
Skeletal muscle mass and sarcopenia in nonalcoholic fatty liver disease.
P. Panjawatanan (2019)
Sarcopenia in liver disease
S. Nishiguchi (2018)